122 related articles for article (PubMed ID: 12077112)
1. Inhibition of nucleoside transport by p38 MAPK inhibitors.
Huang M; Wang Y; Collins M; Gu JJ; Mitchell BS; Graves LM
J Biol Chem; 2002 Aug; 277(32):28364-7. PubMed ID: 12077112
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nucleoside transport by protein kinase inhibitors.
Huang M; Wang Y; Cogut SB; Mitchell BS; Graves LM
J Pharmacol Exp Ther; 2003 Feb; 304(2):753-60. PubMed ID: 12538831
[TBL] [Abstract][Full Text] [Related]
3. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.
Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE
Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472
[TBL] [Abstract][Full Text] [Related]
4. Regulation of equilibrative nucleoside uptake by protein kinase inhibitors.
Huang M; Wang Y; Mitchell BS; Graves LM
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1445-50. PubMed ID: 15571274
[TBL] [Abstract][Full Text] [Related]
5. CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase.
Huang M; Wang Y; Collins M; Graves LM
Leukemia; 2004 Nov; 18(11):1857-63. PubMed ID: 15385935
[TBL] [Abstract][Full Text] [Related]
6. Complex effects of sulfhydryl reagents on ligand interactions with nucleoside transporters: evidence for multiple populations of ENT1 transporters with differential sensitivities to N-ethylmaleimide.
Vyas S; Ahmadi B; Hammond JR
Arch Biochem Biophys; 2002 Jul; 403(1):92-102. PubMed ID: 12061806
[TBL] [Abstract][Full Text] [Related]
7. Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells.
Kohmura K; Miyakawa Y; Kawai Y; Ikeda Y; Kizaki M
J Cell Physiol; 2004 Mar; 198(3):370-6. PubMed ID: 14755542
[TBL] [Abstract][Full Text] [Related]
8. Nucleoside transport in rat erythrocytes: two components with differences in sensitivity to inhibition by nitrobenzylthioinosine and p-chloromercuriphenyl sulfonate.
Jarvis SM; Young JD
J Membr Biol; 1986; 93(1):1-10. PubMed ID: 3025447
[TBL] [Abstract][Full Text] [Related]
9. Functional expression of the nitrobenzylthioinosine-sensitive nucleoside transporter of human choriocarcinoma (BeWo) cells in isolated oocytes of Xenopus laevis.
Boumah CE; Harvey CM; Paterson AR; Baldwin SA; Young JD; Cass CE
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):769-73. PubMed ID: 8192666
[TBL] [Abstract][Full Text] [Related]
10. The role of p38 mitogen-activated protein kinase in IL-1 beta transcription.
Baldassare JJ; Bi Y; Bellone CJ
J Immunol; 1999 May; 162(9):5367-73. PubMed ID: 10228013
[TBL] [Abstract][Full Text] [Related]
11. GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen-activated protein kinase.
Somwar R; Kim DY; Sweeney G; Huang C; Niu W; Lador C; Ramlal T; Klip A
Biochem J; 2001 Nov; 359(Pt 3):639-49. PubMed ID: 11672439
[TBL] [Abstract][Full Text] [Related]
12. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
Hammond JR
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.
Belt JA
Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117
[TBL] [Abstract][Full Text] [Related]
14. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation.
Konrad D; Somwar R; Sweeney G; Yaworsky K; Hayashi M; Ramlal T; Klip A
Diabetes; 2001 Jun; 50(6):1464-71. PubMed ID: 11375349
[TBL] [Abstract][Full Text] [Related]
15. Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK.
Huang HM; Chiou HY; Chang JL
J Cell Biochem; 2006 Jul; 98(4):789-97. PubMed ID: 16440334
[TBL] [Abstract][Full Text] [Related]
16. Differential inhibition of nucleoside transport systems in mammalian cells by a new series of compounds related to lidoflazine and mioflazine.
Griffith DA; Conant AR; Jarvis SM
Biochem Pharmacol; 1990 Nov; 40(10):2297-303. PubMed ID: 2244931
[TBL] [Abstract][Full Text] [Related]
17. Glutathione depletion in CYP2E1-expressing liver cells induces toxicity due to the activation of p38 mitogen-activated protein kinase and reduction of nuclear factor-kappaB DNA binding activity.
Wu D; Cederbaum A
Mol Pharmacol; 2004 Sep; 66(3):749-60. PubMed ID: 15322268
[TBL] [Abstract][Full Text] [Related]
18. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance.
Barancík M; Bohácová V; Kvackajová J; Hudecová S; Krizanová O; Breier A
Eur J Pharm Sci; 2001 Aug; 14(1):29-36. PubMed ID: 11457647
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes.
Kayali AG; Austin DA; Webster NJ
Diabetes; 2000 Nov; 49(11):1783-93. PubMed ID: 11078444
[TBL] [Abstract][Full Text] [Related]
20. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
